Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W W Overwijk

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 11, 2000
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responsesK Lee, W W Overwijk, M O'Toole, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100Y Zhai, J C Yang, P Spiess, et al.
Blood|April 6, 2001
Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirusJ P Zoeteweij, A V Moses, A S Rinderknecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineV Bronte, M W Carroll, T J Goletz, et al.
Vaccine|March 9, 2011
Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccinesH J Park, H Qin, S C Cha, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
An autologous oral DNA vaccine protects against murine melanomaR Xiang, H N Lode, T H Chao, et al.
Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 11, 2000
Dose-dependent and schedule-dependent effects of interleukin-12 on antigen-specific CD8 responsesK Lee, W W Overwijk, M O'Toole, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 1, 1997
Cloning and characterization of the genes encoding the murine homologues of the human melanoma antigens MART1 and gp100Y Zhai, J C Yang, P Spiess, et al.
Blood|April 6, 2001
Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirusJ P Zoeteweij, A V Moses, A S Rinderknecht, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1997
Antigen expression by dendritic cells correlates with the therapeutic effectiveness of a model recombinant poxvirus tumor vaccineV Bronte, M W Carroll, T J Goletz, et al.
Vaccine|March 9, 2011
Induction of TLR4-dependent CD8+ T cell immunity by murine β-defensin2 fusion protein vaccinesH J Park, H Qin, S C Cha, et al.
The Journal of Experimental Medicine|April 5, 2000
Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapyT A Colella, T N Bullock, L B Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2000
An autologous oral DNA vaccine protects against murine melanomaR Xiang, H N Lode, T H Chao, et al.
Cancer Research|November 3, 2001
Immunization against endogenous retroviral tumor-associated antigensM H Kershaw, C Hsu, W Mondesire, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 1999
Vaccination with a recombinant vaccinia virus encoding a "self" antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytesW W Overwijk, D S Lee, D R Surman, et al.
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Pageof 3